Pharmacist’s Strategies in Treating Asthma Bronchiale Outpatien
DOI:
https://doi.org/10.25026/jtpc.v1i3.26Keywords:
asma, pelayanan kefarmasian, drug-related problems, persepsi sakitAbstract
ABSTRACT
Asthma is one of the major health problems in the world. Actual asthma symptoms can be treated and controlled, so that most patients can prevent the onset of symptoms throughout the day, to prevent a serious attack. Pharmacists play a role in pharmaceutical care that aims to find health care system needed to improve drug therapy of complex and significant value of drug-related morbidity and mortality, functions to improve pharmacotherapy outcomes and quality of life of patients with asthma. The patient's belief about health and illness and related behaviors are also very important to the effectiveness of pharmaceutical care. Objective research to study the role of pharmacists in pharmaceutical care in the treatment of outpatient asthma bronchiale. The type of study was cross-sectional. The number of respondents recruited was 22 patients. In this study data were obtained by direct interview using a form of data collection, accompanied by observations of the patients. Result research Patients involved in this study were 22. The total numbers of DRPs were 20 cases (problem-based) and 23 cases (cause-based). The class of drugs causing most DRPs was beta-2 agonist. The subjective perceptions of symptoms experienced by the majority of patients with asthma were: shortness of breath (100%), wheezing sound (90%), fatigue and difficulty sleeping (85%). The cognitive aspect of illness perceived by the patients regarding identity, cause of illness and cure or control was correct, but those concerning consequences and timeline were still lacking. This study demonstrates that the role of pharmacists in pharmaceutical care in ambulatory asthma patients has a nature of direct counseling to patients and monitoring. Monitoring of patients on a regular basis and analysis of the occurrence of drug-related problems might help the patients to get effective, safe and rational treatment.
Keywords: asthma, pharmaceutical care, drug related problems, illness perception
ABSTRAK
Asma adalah salah satu masalah kesehatan utama dunia. Gejala asma yang sebenarnya dapat diobati dan dikendalikan sehingga mencegah serangan yang serius. Apoteker perlu memainkan perannya dalam pharmaceutical care (pelayanan kefarmasian) yang bertujuan untuk menemukan sistem perawatan kesehatan yang diperlukan untuk meningkatkan nilai terapi obat kompleks dan signifikan obat morbiditas dan mortalitas terkait, berfungsi untuk meningkatkan hasil farmakoterapi dan kualitas hidup pasien asma. Persepsi pasien terhadap kesehatan dan penyakit terkait juga sangat penting utnuk efektifitas perawatan farmasi. Penelitian ini bertujuan untuk mempelajari peran apoteker dalam perawatan farmasi dalam pengobatan rawat jalan asma bronkial. Jenis penelitian ini adalah cross-sectional. Jumlah responden 22 Pasien. Data diperoleh dengan wawancara langsung untuk mengumpulkan data, disertai dengan pengamatan dari pasien. Hasil: jumlah drug-related problems (DRPs) adalah 20 kasus (problem based) dan 23 kasus (caused-based). Kelas obat yang menyebabkan DRPs terbanyak adalah beta-2 agonis. Pesrsepsi subjektif dari gejala yang dialami oleh sebagian besar pasien dengan asma adalah : sesak napas (100%), suara mengi (90%), kelelahan dan kesulitan tidur (85%). Aspek kognitif penyakit yang dirasakan oleh pasien mengenai identitas, penyebab penyakit dan menyembuhkan atau mengendalikan penyakit adalah benar, tetapi tentang konsekuensi dan timeline masih kurang. Penelitian ini menunjukkan bahwa peran apoteker dalam perawatan farmasi pada pasien asma rawat jalan memiliki sifat konseling langsung ke pasien dan pemantauan. Pemantauan pasien secara teratur dan analisis terjadinya DRPs untuk membantu pasien mendapatkan pengobatan yang efektif, aman dan rasional.
Kata kunci: asma, pelayanan kefarmasian, drug-related problems, persepsi sakit
Downloads
References
2.Schulz, M.; Verheyen, F.; Muhlig, S.; Muller, J.M.; Muhlbauer, K.; Knop-Schneickert, E.; Petermann, F.; & Bergmann, K.C. 2001,Pharmaceutical care services for asthma patients: a controlled intervention study.J. Clin. Pharmacol41: 668-76.
3.National Asthma Education and Prevention Program. 1997,Guidelines for the diagnosis and management of asthma: Expert Panel Report 2. National Institutes of Health: National Heart, Lung, and Blood Institute.
4.Mangunrejo, H.; Widjaja, A.; Kusumo, D.; Sutoyo.; Yunus, F.; Pradjnaporamita, et al. 2004, Pedoman Diagnosis dan Penatalaksanaan di Indonesia: Asma. Perhimpunan Dokter Paru Indonesia.
5.Abdelhamid, E.; Awad, A.; & Gismallah, A.2008,Evaluation of a Hospital Pharmacy-Based Pharmaceutical Care Services for Asthma Patients, Pharmacy Practice6(1):25-32.
6.Berenguer, B.; La Cassa, C.; de La Matta, M.J.; & Martin-Calero, M.J. 2004,Pharmaceutical Care: Past, Present and Future. Curr. Pharm.10(31):3931-46.
7.Farris, K.B.; Fernandez-Llimos, F.; & Benrimoj, S.I. 2005,Pharmaceutical care in community pharmacies: Practice and research from around the world, Ann. Pharmacotherapy39:539-41.
8.Bootman, L. 2007,Drug Related Morbidity and Mortality Impact of Pharmaceutical Care.
World Health Organization: Essensial Medicines and Policy Department (EDM): International Conferences on Improving Use of Medicines (ICIUM) [online] [cited 2010 January 21].
9.American Society of Health-System Pharmacists. 1996,ASHP Guidelines on a
Standardized Method for Pharmaceutical Care. Am. J. Health-Syst Pharm.53: 1713–6.
10.Corelli, R.L.; Kradjan, W.A.; Koda-Kimble, M.A.; Young, L.Y.; Guglielmo, B.J.; & Alldredge, B.K. 2005,Assessment of Therapy and Pharmaceutical Care. In: Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Corelli RL, editors. Applied Therapeutics: The Clinical Use of Drugs. 8thed. Lippincortt Williams & Wilkins. Philadelphia; p1.1-1.21.
11.Mill, F.V. 2005,Drug-related Problems: A Cornerstone for Pharmaceutical Care, J.the Malta College of Pharmacy Practice.
12.Blix,H.; Vitkil, K.; Asmund, R.; Tron, M.; Bodil, H.; Piia, P.; et al. 2004,The Majority of
Hospitalised Patients Have Drug-Related Problems: Result from A Prospective Study in General Hospitals, Eur. J. Clin. Pharmacology
13.Lahdensuo, A.; Haahtela, T.; Herrala, J.; Kava, T.; Kiviranta, K.; Kuusisto, P.; Perämäki, E.; Poussa, T.; Saarelainen, S.; & Svahn, T. 1996,Randomised comparison of guided self management and traditional treatment of asthma over one year, BMJ 312:748-52.
14.Beasley, R.; Cushley, M.; & Holgate, S.T. 1989,A self-management plan in the treatment of adult asthma. Thorax 44:200-4.
15.Gibbs, K.; Small, M.; Asthma. In: Walker, R,; & Clive, E.; eds. 2003,Clinical Pharmacy and Therapeutics. 3rded. Churchill Livingstone; p375-398.
16.Harding, G.; & Taylor, K. 2002,Social Dimension of Pharmacy: (4) Health, Illness and Seeking Health Care. The Pharmaceutical J.; p269.
17.Cordina, M.; McElany, J.C.; & Hughes, C.M. 2001,Assessment of a community Pharmacy-Based program for patients with asthma. Pharmacotherapy 21(10):1196-203.
18.Broadbent E, Petrie KJ, Main J, Weinman J. 2006. The Brief Illness Perception Questionnaire. J. Psychosomatic Research60: 631– 637.
19.Asthma Management Handbook. 2006,National Asthma Council Australia.
20.Standards of Medical Care in Diabetes: American Diabetes Association. 2009,Diabetes Care 32(1).
21.Lacy, C.; Armstrong, L.; Goldman, M.; & Lance, L. 2006,Drug Information Handbook: A Comprehensive Resource for all Clinicians and Healthcare Professionals. 14thed. Lexi-Comp Inc. United States.
22.National Endocrine and Metabolic Diseases Informaton Service: A Service o The Institute of Diabetes and Digestive and Kidney Diseases. 2009,NIH [online] [cited 2010 January 21]. Available from URL:http://www.endocrine.niddk.gov/
23.Baxter Karen, ed. 2006,Stockley’s Drug Interactions. 7thed. Pharmaceutical Press; London p1-11, 697.
24.Ogden, J. 2007,Health Psychology: A textbook4th ed. London.
25.Marieb, N. 2004,Esssentials of Human Anatomy and Physiology. 4th edition; United States
